DsbA-L has been found to be widely involved in inflammation, insulin resistance, renal tubular damage, and adiponectin multimerization (Bai et al. 2017; Yang et al. 2019; Zhou et al. 2020; Oniki et al. 2020a). Here, ADIPOQ is linked to Insulin resistance.